Ключевые слова
Аннотация
Ushbu ish o‘pka arteriyasi tromboemboliyasi bilan og‘rigan bemorlarda tizimli trombolizis terapiya, xususan Alteplaza, samaradorligini baholashga qaratilgan. Tadqiqot natijalari shuni ko‘rsatadiki, terapiya yurak va o‘pka funksiyasini tiklash, o‘lim xavfini kamaytirish va bemorlarning hayot sifatini yaxshilashda muhim rol o‘ynaydi. Shu bilan birga, qon ketishi va boshqa asoratlar xavfi monitoringni talab qiladi. Ushbu ish klinik amaliyotda davolash strategiyalarini takomillashtirish va xavfsiz, samarali terapiyani ta’minlashga hissa qo‘shadi.
Библиографические ссылки
Mathew, D., Seelam, S., Bumrah, K., et al. (2023). Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: A systematic review and meta analysis. BMC Cardiovascular Disorders, 23, 482.
Salinas, P. (2024). Underuse of systemic thrombolysis in pulmonary embolism: A single center retrospective observational study. ScienceDirect.
Sukovatykh, A. (2024). The Effectiveness of Systemic Thrombolysis in the Treatment of Massive Pulmonary Embolism. Journal of Experimental and Clinical Surgery.
Comparative efficacy and safety of thrombolytic agents for pulmonary embolism: A Bayesian network meta analysis. Pharmacology, 108, 111–126.
Unat, Ö. S., Korkmaz, P., Çinkooğlu, A., et al. (2025). Comparison of half dose alteplase and LMWH in intermediate high risk pulmonary embolism: a single center observational study. Egyptian Heart Journal, 77, 74